Zoetis Inc.
ZTSAPI behind this page
ZTS Q1 2026 request
Playground key active
/api/financials?ticker=ZTS&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 2,262 | 2,198 | +2.9% |
Show Product Lines breakouts |
|||
| Animal health diagnostics | 117 | 104 | +12.5% |
| Anti-infectives | 241 | 238 | +1.3% |
| Cattle | 392 | 341 | +15.0% |
| Companion Animal [Member] | 1,519 | 1,541 | -1.4% |
| Companion Animal [Member] · International | 654 | 568 | +15.1% |
| Companion Animal [Member] · U.S. | 865 | 973 | -11.1% |
| Contract manufacturing & human health | 23 | 30 | -23.3% |
| Dermatology | 349 | 379 | -7.9% |
| Dogs and Cats | 1,443 | 1,477 | -2.3% |
| Fish | 66 | 55 | +20.0% |
| Horses | 76 | 64 | +18.8% |
| Livestock [Member] | 720 | 627 | +14.8% |
| Livestock [Member] · International | 495 | 417 | +18.7% |
| Livestock [Member] · U.S. | 225 | 210 | +7.1% |
| Manufactured Product Other | 21 | 20 | +5.0% |
| Other Non Pharmaceuticals [Member] | 66 | 71 | -7.0% |
| Other pharmaceutical | 158 | 158 | 0.0% |
| Pain and sedation | 203 | 207 | -1.9% |
| Parasiticides | 586 | 572 | +2.4% |
| Poultry | 118 | 106 | +11.3% |
| Swine [Member] | 123 | 105 | +17.1% |
| Total products and services | 2,239 | 2,168 | +3.3% |
| Vaccines | 519 | 439 | +18.2% |
Show Business Segments breakouts |
|||
| International · Operating Segments | 263 | 225 | +16.9% |
| International · Operating Segments | 1,149 | 985 | +16.6% |
| U.S. · Operating Segments | 1,090 | 1,183 | -7.9% |
Show Geography breakouts |
|||
| AU | 89 | 79 | +12.7% |
| BR | 90 | 81 | +11.1% |
| CA | 73 | 70 | +4.3% |
| CL | 38 | 35 | +8.6% |
| CN | 63 | 55 | +14.5% |
| DE | 59 | 55 | +7.3% |
| ES | 40 | 29 | +37.9% |
| FR | 37 | 39 | -5.1% |
| GB | 78 | 74 | +5.4% |
| IT | 39 | 30 | +30.0% |
| JP | 35 | 32 | +9.4% |
| MX | 48 | 35 | +37.1% |
| Other developed markets | 169 | 133 | +27.1% |
| Other emerging markets | 291 | 238 | +22.3% |
| Total geographical area | 2,239 | 2,168 | +3.3% |
| US | 1,090 | 1,183 | -7.9% |
| Cost of Revenue | 641 | 618 | +3.7% |
Show Business Segments breakouts |
|||
| International · Operating Segments | 334 | 295 | +13.2% |
| U.S. · Operating Segments | 194 | 199 | -2.5% |
| Selling, General & Administrative | 588 | 574 | +2.4% |
| Research And Development Expense Excluding Acquired In Process Cost | 180 | 162 | +11.1% |
| Amortization Of Intangible Assets Not Associated With Single Function | 31 | 32 | -3.1% |
| Restructuring Charges And Acquisition And Divestiture Related Costs | 22 | — | — |
| Interest Expense | 62 | 54 | +14.8% |
| Non-Operating Income (Expense) | -20 | -15 | -33.3% |
Show Business Segments breakouts |
|||
| International · Operating Segments | 1 | — | — |
| Income Before Taxes | 758 | 773 | -1.9% |
Show Business Segments breakouts |
|||
| All Other Segments | -141 | -133 | -6.0% |
| International · Operating Segments | 639 | 527 | +21.3% |
| U.S. · Operating Segments | 697 | 779 | -10.5% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -315 | -278 | -13.3% |
| Operating Segments | 1,336 | 1,306 | +2.3% |
| Income Tax Expense (Benefit) | 157 | 171 | -8.2% |
| Net Income | 601 | 602 | -0.2% |
Show Equity Components breakouts |
|||
| Retained Earnings | 601 | 602 | -0.2% |
| Net Income | 601 | 602 | -0.2% |
| EPS (Basic) | 1.42 | 1.34 | +6.0% |
| EPS (Diluted) | 1.42 | 1.34 | +6.0% |
| Wtd Avg Shares (Basic) | 422.1 | 447.6 | -5.7% |
| Wtd Avg Shares (Diluted) | 422.4 | 448 | -5.7% |
| Common Stock Dividends Per Share Declared | 0.53 | 0.5 | +6.0% |
| Gross Profit (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International · Operating Segments | 815 | 690 | +18.1% |
| U.S. · Operating Segments | 896 | 984 | -8.9% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International · Operating Segments | 175 | 163 | +7.4% |
| U.S. · Operating Segments | 199 | 205 | -2.9% |
| Other Non-Operating Income (Expense) | 1 | -3 | +133.3% |
| Comprehensive Income | 633 | 690 | -8.3% |
| Foreign Currency Transaction Gain Loss Before Tax | 6 | 10 | -40.0% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,941 | 1,721 | +12.8% |
| Accounts Receivable | 1,506 | 1,361 | +10.7% |
| Inventory | 2,550 | 2,365 | +7.8% |
| Other Assets Current | 477 | 430 | +10.9% |
| Total Current Assets | 6,474 | 5,877 | +10.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 3,719 | 3,441 | +8.1% |
| Operating Lease Right-of-Use Assets | 282 | 220 | +28.2% |
| Goodwill | 2,778 | 2,716 | +2.3% |
Show Geography breakouts |
|||
| Non Us | 1,263 | — | — |
| US | 1,515 | 1,515 | 0.0% |
| Deferred Tax Assets | 591 | 530 | +11.5% |
| Other Non-Current Assets | 351 | 232 | +51.3% |
| Total Assets | 15,154 | — | — |
| Intangible Assets | 745 | 875 | -14.9% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 557 | 678 | -17.8% |
| Other Intangible Assets | 79 | 78 | +1.3% |
| Trademarks And Trade Names | 109 | 119 | -8.4% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 959 | 1,082 | -11.4% |
| Current Liabilities | |||
| Accounts Payable | 507 | 420 | +20.7% |
| Dividends Payable Current | 224 | 224 | 0.0% |
| Other Accrued Liabilities Current | 751 | 772 | -2.7% |
| Employee Related Liabilities Current | 239 | 291 | -17.9% |
| Taxes Payable Current | 211 | 211 | 0.0% |
| Other Liabilities Current | 121 | 117 | +3.4% |
| Total Current Liabilities | 2,053 | 3,385 | -39.4% |
| Non-Current Liabilities | |||
| Long-Term Debt | 9,045 | 5,227 | +73.0% |
| Deferred Tax Liabilities | 130 | 161 | -19.3% |
| Operating Lease Liabilities | 193 | 173 | +11.6% |
| Accrued Income Taxes Noncurrent | 281 | 277 | +1.4% |
| Other Non-Current Liabilities | 219 | 220 | -0.5% |
| Total Liabilities | 11,921 | — | — |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Treasury Stock Value | -11,288 | -7,888 | -43.1% |
| Additional Paid-In Capital | 1,105 | 1,180 | -6.4% |
| Retained Earnings | 14,183 | 12,375 | +14.6% |
| Accumulated Other Comprehensive Income | -772 | -1,017 | +24.1% |
| Total Stockholders' Equity | 3,233 | 4,655 | -30.5% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3,233 | 4,865 | -33.5% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 3 | 1 | +200.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 68 | 76 | -10.5% |
| Accumulated Net Unrealized Investment Gain Loss | -25 | 29 | -186.2% |
| Accumulated Other Comprehensive Income | -772 | -922 | +16.3% |
| Accumulated Translation Adjustment | -818 | -1,028 | +20.4% |
| Additional Paid In Capital | 1,105 | 1,180 | -6.4% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | 14,183 | 12,490 | +13.6% |
| Treasury Stock Common | -11,288 | -7,888 | -43.1% |
| Total Liabilities & Equity | 15,154 | 14,098 | +7.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 119 | 119 | 0.0% |
Show Business Segments breakouts |
|||
| All Other Segments | 13 | 11 | +18.2% |
| International · Operating Segments | 26 | 23 | +13.0% |
| U.S. · Operating Segments | 23 | 23 | 0.0% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 25 | 29 | -13.8% |
| Operating Segments | 49 | 46 | +6.5% |
| Stock-Based Compensation | 25 | 17 | +47.1% |
| Gain Loss On Sales Of Assets And Asset Impairment Charges | -6 | — | — |
| Inventory Write Down | 13 | 19 | -31.6% |
| Deferred Income Taxes | 34 | 14 | +142.9% |
| Cash Received From Payments To Settle Derivative Instruments | -3 | — | — |
| Other Non-Cash Items | 3 | -1 | +400.0% |
| Change in Accounts Receivable | -106 | -46 | -130.4% |
| Change in Inventory | -114 | -85 | -34.1% |
| Increase Decrease In Other Operating Assets | -66 | -46 | -43.5% |
| Change in Accounts Payable | 62 | 22 | +181.8% |
| Increase Decrease In Other Operating Liabilities | -234 | -206 | -13.6% |
| Increase Decrease In Accrued Taxes Payable | 73 | 104 | -29.8% |
| Net Cash from Operations | 401 | 515 | -22.1% |
| Investing Activities | |||
| Capital Expenditures | -110 | -178 | +38.2% |
| Payments To Acquire Investments | -2 | -2 | 0.0% |
| Payments For Proceeds From Hedge Investing Activities | 16 | -24 | +166.7% |
| Proceeds From Sale Of Property Plant And Equipment | 10 | — | — |
| Other Investing Activities | -1 | 1 | -200.0% |
| Net Cash from Investing | -87 | -203 | +57.1% |
| Excise Tax Accrued On Net Share Repurchased Not Paid | 6 | 4 | +50.0% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 10 | 7 | +42.9% |
| Dividends Payable Current And Noncurrent | 224 | 224 | 0.0% |
| Financing Activities | |||
| Share Based Compensation Related Proceeds Net Of Taxes Paid On Withholding Shares | -7 | -9 | +22.2% |
| Share Repurchases | -606 | -443 | -36.8% |
| Payments Of Ordinary Dividends | -224 | -224 | 0.0% |
| Proceeds From Payments For Other Financing Activities | -3 | -1 | -200.0% |
| Net Cash from Financing | -840 | -677 | -24.1% |
| Supplemental | |||
| Income Taxes Paid | 50 | 60 | -16.7% |
| Interest Paid | 109 | 68 | +60.3% |
| Operating Lease Payments | 17 | 16 | +6.2% |
| Unpaid Capital Expenditures | 3 | 3 | 0.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 17 | 33 | -48.5% |
| Net Change in Cash | -509 | -332 | -53.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,941 | 1,782 | +8.9% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.